Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia: results of a randomised placebo-controlled trial

Carin Uyl - de Groot, E Vellenga, EGE de Vries, Bob Löwenberg, GJ Stoter, FFH Rutten

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)351-360
Number of pages10
JournalPharmacoeconomics (Print)
Volume12
Issue number3
Publication statusPublished - 1997

Research programs

  • EUR ESHPM 02

Cite this